Gwen Lemey is a Postdoctoral Researcher at the Global Health Institute (GHI), University of Antwerp. Holding master’s degrees in African Languages and Cultures (2005) and International Affairs and Diplomacy (2006), she joined GHI in 2013 as Project Coordinator, overseeing donor-funded research projects across Central and East Africa. She has contributed to an Ebola vaccine trial (2019-2022) with the Janssen vaccine, in partnership with the University of Kinshasa, DR Congo. Her PhD (2022–2025) explored research ethics and ancillary care in resource-constrained settings. Currently, in the PregInPoxVac Phase 3 trial‒evaluating mpox vaccine immunogenicity and safety in maternal-infant cohorts‒she builds further on this expertise. Gwen is passionate about ethical global health practices and equitable research in low-resource contexts.